CTCF mutation at R567 causes developmental disorders via 3D genome rearrangement and abnormal neurodevelopment

Jie Zhang1,2, Gongcheng Hu3, Yuli Lu1,4

  • 1State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.

PubMed

Insights

A CTCF mutation (R567W) impairs development, causing mortality and neurodevelopmental issues in mice and human organoids. This research reveals mechanisms behind CTCF-related developmental disorders.

Area of Science:

  • Genomics
  • Developmental Biology
  • Molecular Biology

Background:

  • The three-dimensional genome organization by CTCF is crucial for development.
  • Clinical mutations in CTCF are associated with adverse developmental outcomes, but mechanisms are unclear.

Purpose of the Study:

  • To investigate the regulatory roles of a specific CTCF R567W mutation.
  • To elucidate the impact of this mutation on murine and human embryonic stem cell-derived cortical organoid models.

Main Methods:

  • Introduction of the CTCF R567W mutation into murine models and human cortical organoids.
  • Pathological and single-cell transcriptome analysis.
  • Assessment of CTCF binding, chromatin structure, and gene expression.

Main Results:

  • Homozygous CTCF R567W mice showed growth impediments, postnatal mortality, and developmental deviations in brain, heart, and lungs.
  • The mutation led to premature stem cell exhaustion, accelerated GABAergic neuron maturation, and disrupted neurodevelopmental and synaptic pathways.
  • CTCF R567W hindered CTCF binding to peripheral motifs, altering chromatin and gene expression, notably at the protocadherin locus. Human organoid models mirrored these effects.

Conclusions:

  • The CTCF R567W mutation significantly impacts neurodevelopment, offering insights into human neurodevelopmental disorders.
  • This study provides a foundation for developing potential therapeutic interventions for CTCF-related developmental conditions.